Medical Cannabis Market Growth, Future Trends, Share Value, Regional Outlook and Size Projection by 2027

 

Medical Cannabis Market Highlights

Medical cannabis, also known as medical marijuana, is an herbal drug derived from plants of the genus Cannabis used to treat a specific symptom or disease. Although the word cannabis refers specifically to the plant genus, it is also used interchangeably with marijuana, which describes the crude drug isolated from the plants’ leaves and flowers.

The global Medical Cannabis Market Size is expected to cross USD 33,210.21 million by 2027 at a CAGR of 18.14% during the forecast period 2020-2027.

The key factors that drive the global medical cannabis market are the rising research & development activities and financial support by various government and private organizations for cannabinoid research. However, stringent government policies and increasing illegal use of marijuana sizes are anticipated to hamper the market growth.

Regional Analysis

The Americas dominated the global medical cannabis market report by accounting for the largest share in 2020. This large market share is due to medical cannabis legalization in 37 US states and the increasing adoption of products. The presence of major manufacturers, the rising adoption of medical cannabis products, and an increasing number of companies involved in R&D activities are driving the growth of the market in this region. Europe holds a strong share in the global medical cannabis market. It is the second-largest market due to an increasing number of European countries legalizing cannabis for medical purposes.

Additionally, prominent research and manufacturing activities in the region are anticipated to increase the market size in this region. The increasing prevalence of diseases such as multiple sclerosis, epilepsy, Alzheimer’s disease, Parkinson’s disease, post-traumatic stress disorder, depression, and anxiety are fuelling the market growth in Europe. Asia-Pacific is expected to have a favourable growth rate during the forecast period, owing to the huge patient pool of cancer and government initiatives of healthcare reforms. It holds the third-largest position in the global medical cannabis market. The Middle East would depict the least growth due to major factors, such as underdeveloped regulations and lower adoption rates. The region is expected to witness a restricted growth due to stringent government policies.

Segment Analysis

The global medical cannabis market has been segmented based on product type, derivative, route of administration, application, and distribution channel.

The market, based on product type, has been segregated into solid, dissolvable/powders, oil, and ointment & creams. Based on derivative, the market is bifurcated into cannabidiol and tetrahydrocannabinol. Based on route of administration, the global medical cannabis market has been segmented into inhalation, oral, and topical.

Based on application it is divided into pain management, neurological health management, and mental health management. The inhalation segment dominated the market segment is expected to register the fastest growth in the application segment of the global medical cannabis market during the forecast period. The medical cannabis market, by distribution channel, is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.

Medical Cannabis Market Players

The global medical cannabis market players - Canopy Growth Corporation (Canada), Cannabis Sativa, Inc. (US), GW Pharmaceuticals plc. (UK), Emerald Health Therapeutics (Canada), Tilray, Inc. (Canada), Aurora Cannabis Inc. (Canada), Cara Therapeutics (US), Medical Marijuana, Inc. (US), GB Sciences, Inc. (US), and Canndoc (Israel).

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Macrolide Antibiotics Market Competitive Landscape, Future Plans and Global Trends by Forecast 2030

  Macrolide Antibiotics Market Highlights Macrolides such as azithromycin, clarithromycin, and erythromycin are a class of antibiotics that inhibit protein synthesis. It acts as a bacteriostatic agent against many strains of corynebacterial, listeria, moxicella, streptococci, Neisseria meningitides, Staphylococci, Clostridia, and Haemophilus sp. It is used for the treatment of bacterial infections, such as nose, ear, and throat infections, chest infections, skin infections as well as mouth and dental infections. They are also used as an alternative to penicillin. The global macrolide antibiotics market is expected to show a sharp growth over the forecast period owing to an increasing demand for macrolide across the globe. Rising prevalence of bacterial skin infections and rising number of dermatology clinics also favour the market growth.  According to a study published in the Journal of the American College of Cardiology, macrolide antibiotics may increase the ...
Read more

Atorvastatin API Market Competitive Landscape, Future Plans and Global Trends by Forecast 2030

  Atorvastatin API Market Highlights The hypercholesterolemia segment is expected to lead the market and register a substantial CAGR to reach USD 2,10,753.23 thousand by the end of 2023. High prevalence of hypercholesterolemia is expected to drive the market growth. Additionally, the segment is projected to exhibit the highest CAGR of 4.09% from 2018 to 2023. The atorvastatin API market is anticipated to reach USD 2,852.3 Million by 2030 at 7.50% CAGR during the forecast period 2022-2030. North America accounted for the largest market share of 40.64% in 2017, and the regional market is projected to register a CAGR of 3.10% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Chinese market is projected to exhibit the highest growth rate of 5.86% during the forecast period from 2022 to 2030. Atorvastatin API Market Segmentation The atorvastatin API market report has been studied extensively by MRFR experts, with respect to applications. ...
Read more

Nutrigenomics Market | Global Analysis, Statistics, Revenue, Demand and Trend Analysis Research Report by 2030

Market Highlights Following the analysis of the latest trends across the globe, Market Research Future (MRFR) states that the nutrigenomics market is projected to reach the valuation of  USD 464.76 Million by 2030 . In addition, the market is expected to surge at a growth rate of  15.70% during the forecast period ( 2022-2030 ). The Nutrigenomics market is one that has emerged in the past few years, carrying with it a massive potential. With the global statistics for obesity, lifestyle diseases and the ever-increasing demand for effective cosmetic treatments, nutrigenics has risen up as a potential treatment option. Growth Drivers and Key Restraints The boost in the awareness levels among consumers coupled with the rising prevalence of obesity across the globe is predicted to be a crucial factor elevating the market position of nutrigenomics. The surging trend of personalized diet, particularly among athletes will also be beneficial for the market in the near future. ...
Read more